Tenofovir alafenamide/tenofovir disoproxil fumarateAcute tubular necrosis: case report

被引:0
作者
机构
关键词
D O I
10.1007/s40278-021-00845-2
中图分类号
学科分类号
摘要
引用
收藏
页码:388 / 388
相关论文
共 50 条
[41]   Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide [J].
Podany, Anthony T. ;
Bares, Sara H. ;
Havens, Joshua ;
Dyavar, Shetty Ravi ;
O'Neill, Jennifer ;
Lee, Sarah ;
Fletcher, Courtney V. ;
Swindells, Susan ;
Scarsi, Kimberly K. .
AIDS, 2018, 32 (06) :761-765
[47]   Atherosclerotic CVD risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate [J].
Huhn, G. ;
Shamblaw, D. ;
Baril, J. G. ;
Baker, D. ;
Ward, D. ;
Guo, S. ;
Haubrich, R. ;
Nguyen-Cleary, T. ;
McCallister, S. ;
Das, M. .
ANTIVIRAL THERAPY, 2016, 21 :A45-A45
[49]   Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? [J].
Hill, A. ;
Hughes, S. ;
Pozniak, A. .
HIV MEDICINE, 2018, 19 :S30-S30
[50]   Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2 [J].
Cusato, Jessica ;
Calcagno, Andrea ;
De Nicolo, Amedeo ;
Mogyorosi, Karoly ;
D'Avolio, Antonio ;
Di Perri, Giovanni ;
Bonora, Stefano .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (02) :202-204